20 May 2013
Keywords: roche, xeloda, gets, ec, ok, bowel, cancer
Article | 14 February 2008
Swiss drug major Roche says its oral chemotherapy product Xeloda (capecitabine) has received European Commission approval for the
treatment of ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
11 February 2008
18 February 2008
17 May 2013
© 2013 thepharmaletter.com